Literature DB >> 8572737

Effect of HLA type and hypocomplementaemia on the expression of parvovirus arthritis: one year follow up of an outbreak.

N S Gendi1, K Gibson, B P Wordsworth.   

Abstract

OBJECTIVES: To determine the effect of HLA type and hypocomplementaemia on the duration and severity of joint involvement in parvovirus infection (HPV).
METHODS: Forty seven patients were selected on a geographical basis from 83 with proven HPV infection during an outbreak that occurred in Oxfordshire in 1993. They were contacted by questionnaire a year later. Thirty five patients were available for examination and blood sampling. Subjects were typed for HLA-DRB1 alleles and HLA-B27 status. Immunological profiles, including C3 and C4 complement components, were determined.
RESULTS: Joint symptoms occurred in all patients. They resolved within a week in 12 patients and persisted beyond one year in 19. On review, none had a picture of rheumatoid arthritis, but three patients had developed carpal tunnel syndrome. Decreased C4 was found in four. The HLA frequencies were similar to those in controls; however, joint symptoms persisted for more than one week in all HLA-DR4 positive patients (p = 0.009). There was no relation between the severity of joint symptoms and either HLA type, or hypocomplementaemia.
CONCLUSIONS: Joint symptoms are common in parvovirus infection and the presence of HLA-DR4 may be associated with persistence of joint symptoms beyond one week. This study revealed no evidence of progression to rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8572737      PMCID: PMC1010084          DOI: 10.1136/ard.55.1.63

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  HLA and acute arthritis following human parvovirus infection.

Authors:  P T Klouda; S A Corbin; B A Bradley; B J Cohen; A D Woolf
Journal:  Tissue Antigens       Date:  1986-11

2.  Arthritis Health Professions Association. Scientific abstracts. 1986 regional meetings.

Authors: 
Journal:  Arthritis Rheum       Date:  1987-01

3.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

4.  Lupus-like presentation of human parvovirus B19 infection.

Authors:  R A Kalish; A N Knopf; G W Gary; J J Canoso
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

5.  Human parvovirus infection in early rheumatoid and inflammatory arthritis.

Authors:  B J Cohen; M M Buckley; J P Clewley; V E Jones; A H Puttick; R K Jacoby
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

6.  HLA class I typing by PCR: HLA-B27 and an African B27 subtype.

Authors:  A V Hill; C E Allsopp; D Kwiatkowski; N M Anstey; B M Greenwood; A J McMichael
Journal:  Lancet       Date:  1991-03-16       Impact factor: 79.321

7.  Transient rheumatoid factor positivity in acute human parvovirus B19 infection.

Authors:  S J Naides; E H Field
Journal:  Arch Intern Med       Date:  1988-12

8.  HLA-DR typing using DNA amplification by the polymerase chain reaction and sequential hybridization to sequence-specific oligonucleotide probes.

Authors:  B P Wordsworth; C E Allsopp; R P Young; J I Bell
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

9.  Influence of previous exposure to human parvovirus B19 infection in explaining susceptibility to rheumatoid arthritis: an analysis of disease discordant twin pairs.

Authors:  A H Hajeer; A J MacGregor; A S Rigby; W E Ollier; D Carthy; A J Silman
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

10.  Human parvovirus arthropathy.

Authors:  D G White; A D Woolf; P P Mortimer; B J Cohen; D R Blake; P A Bacon
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

View more
  6 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Persistent parvovirus b19 infection resulting in carpal tunnel syndrome.

Authors:  Monica Musiani; Elisabetta Manaresi; Giorgio Gallinella; Marialuisa Zerbini
Journal:  J Clin Pathol       Date:  2007-04-05       Impact factor: 3.411

Review 3.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19.

Authors:  Victoria Kasprowicz; Adiba Isa; Thomas Tolfvenstam; Katie Jeffery; Paul Bowness; Paul Klenerman
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

5.  Prolonged activation of virus-specific CD8+T cells after acute B19 infection.

Authors:  Adiba Isa; Victoria Kasprowicz; Oscar Norbeck; Andrew Loughry; Katie Jeffery; Kristina Broliden; Paul Klenerman; Thomas Tolfvenstam; Paul Bowness
Journal:  PLoS Med       Date:  2005-11-01       Impact factor: 11.069

Review 6.  Neurological aspects of human parvovirus B19 infection: a systematic review.

Authors:  Faraj Barah; Sigrid Whiteside; Sonia Batista; Julie Morris
Journal:  Rev Med Virol       Date:  2014-01-24       Impact factor: 6.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.